Manufacturing standards Production in FDA-registered, GMP-certified facilities provides meaningful quality assurance
The BPC-157 + TB-500 Wolverine Stack and Injury Recovery Peptide Protocol use 24 mg of TB-4 or TB-500 per injection
Input your vial size, reconstitution volume, and desired dose, and you'll get the precise injection amount in units or mL
TB-500, a synthetic fragment corresponding to the active region of the endogenous peptide Thymosin Beta-4, drives the cellular migration phase of repair by sequestering G-actin, promoting cell motility, and mobilising stem and progenitor cells to sites of tissue disruption
At tendon injury sites, BPC-157 increases type I collagen expression and stimulates tendon fibroblast migration within 24 hours of exposure in explant cultures